We are live on ! Find out more
PG

Prostatis Group Portfolio holdings

AUM $391M
1-Year Est. Return 20.37%
This Fund
S&P 500
This Quarter Est. Return
+4.78%
1 Year Est. Return
+20.37%
3 Year Est. Return
+56.13%
5 Year Est. Return
+74.88%
10 Year Est. Return
AUM
$215M
AUM Growth
+$25.5M
Cap. Flow
+$7.11B
Cap. Flow %
3,306.68%
Top 10 Hldgs %
45.2%
Holding
253
New
155
Increased
83
Reduced
10
Closed
3

Sector Composition

Rank Sector Weight
1 Technology 3.03%
2 Industrials 2.47%
3 Consumer Staples 1.65%
4 Financials 1.63%
5 Consumer Discretionary 1.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLF icon
76
State Street Financial Select Sector SPDR ETF
XLF
$54.8B
$434K 0.2%
435,014
+426,003
+4,728% +$13.9M
RTX icon
77
RTX Corp
RTX
$261B
$421K 0.2%
+359,655
New +$35.2M
XLV icon
78
State Street Health Care Select Sector SPDR ETF
XLV
$41.4B
$414K 0.19%
385,925
+382,607
+11,531% +$50.4M
LMT icon
79
Lockheed Martin
LMT
$117B
$396K 0.18%
297,096
+296,218
+33,738% +$137M
ARCC icon
80
Ares Capital
ARCC
$13.8B
$375K 0.17%
19,950
-321
-2% -$5.93K
SPYG icon
81
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$51.4B
$370K 0.17%
370,396
+363,947
+5,643% +$20.8M
F icon
82
Ford
F
$56.7B
$350K 0.16%
25,405
+1,842
+8% +$23.3K
MRK icon
83
Merck
MRK
$315B
$349K 0.16%
175,925
+167,711
+2,042% +$19M
ESGU icon
84
iShares ESG Aware MSCI USA ETF
ESGU
$17.7B
$345K 0.16%
+3,538
New +$327K
NEE icon
85
NextEra Energy
NEE
$185B
$329K 0.15%
326,215
+321,131
+6,317% +$24.3M
AMGN icon
86
Amgen
AMGN
$198B
$323K 0.15%
54,976
+49,215
+854% +$11.4M
SUSA icon
87
iShares ESG Optimized MSCI USA ETF
SUSA
$4.01B
$321K 0.15%
+3,430
New +$305K
VHT icon
88
Vanguard Health Care ETF
VHT
$18B
$311K 0.14%
293,646
+292,340
+22,384% +$71.1M
JNJ icon
89
Johnson & Johnson
JNJ
$609B
$308K 0.14%
74,324
+68,564
+1,190% +$11.1M
MCD icon
90
McDonald's
MCD
$190B
$300K 0.14%
137,874
+134,863
+4,479% +$39.2M
UNH icon
91
UnitedHealth
UNH
$387B
$296K 0.14%
73,968
+73,380
+12,480% +$35.9M
MKC icon
92
McCormick & Company Non-Voting
MKC
$13.9B
$286K 0.13%
3,275
-60
-2% -$5.3K
DUK icon
93
Duke Energy
DUK
$97.5B
$286K 0.13%
91,822
+88,863
+3,003% +$8.39M
VDE icon
94
Vanguard Energy ETF
VDE
$9.76B
$271K 0.13%
270,599
+268,085
+10,664% +$30.2M
XLK icon
95
State Street Technology Select Sector SPDR ETF
XLK
$114B
$264K 0.12%
+193,530
New +$15.3M
LHX icon
96
L3Harris
LHX
$52.5B
$263K 0.12%
254,572
+253,258
+19,274% +$48.5M
VTI icon
97
Vanguard Total Stock Market ETF
VTI
$658B
$259K 0.12%
33,409
+32,259
+2,805% +$6.73M
XLP icon
98
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.6B
$249K 0.12%
228,206
+224,576
+6,187% +$16.9M
VGT icon
99
Vanguard Information Technology ETF
VGT
$139B
$247K 0.11%
1,949,096
+1,944,632
+43,563% +$97.7M
TROW icon
100
T. Rowe Price
TROW
$25.1B
$236K 0.11%
2,105

Similar funds

Prostatis Group's Q2 2023 Portfolio in Review

As of Q2 2023, Prostatis Group held 253 positions worth $215M, up 13% from $189M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Prostatis Group deployed $7.11B of net new capital in Q2 2023, opening 155 new positions and adding to 83 existing holdings. Its largest new stake was 3M: 967,937 shares worth $847K.

By sector, the portfolio is most concentrated in Technology at 3% of assets, up from 2.4% a quarter earlier, followed by Industrials and Consumer Staples.

On the sell side, the largest reduction was State Street SPDR S&P Semiconductor ETF, an estimated $615K trimmed.

  • Prostatis Group's largest Q2 2023 buy was 3M: 967,937 shares worth $847K.
  • Prostatis Group added most to Thermo Fisher Scientific in Q2 2023, an estimated $782M increase.
  • Prostatis Group's biggest Q2 2023 reduction was State Street SPDR S&P Semiconductor ETF, cutting an estimated $615K.
  • Prostatis Group fully exited iShares US Healthcare Providers ETF in Q2 2023, selling an estimated $8.63M.
  • Prostatis Group's ten largest holdings make up 45% of its $215M portfolio in Q2 2023.
  • Prostatis Group opened 155 new positions and closed 3 in Q2 2023.
  • Prostatis Group's portfolio value rose 13% quarter-over-quarter to $215M.

Based on Prostatis Group's 13F filing for Q2 2023, filed 14 Aug 2023.